European Commission publishes latest pharma GMP regulation
For active substances for medicinal products for human use
The European Commission has released a text of the latest secondary regulations underpinning European Union (EU) directive 2001/83/EC on good manufacturing practice for active substances for medicinal products for human use.
The latest regulation, approved by the Commission, without reference to the European Parliament and EU ministers, is regulation (EU) No 1252/2014 of May 2014.